iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Down 45.3% in June

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the target of a large drop in short interest in June. As of June 15th, there was short interest totaling 22,477 shares, a drop of 45.3% from the May 31st total of 41,071 shares. Based on an average daily volume of 28,094 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.4% of the shares of the stock are sold short.

iShares Genomics Immunology and Healthcare ETF Stock Performance

Shares of IDNA stock traded up $1.30 during trading hours on Thursday, reaching $34.91. The company had a trading volume of 49,733 shares, compared to its average volume of 43,254. The stock has a fifty day moving average of $30.08 and a 200-day moving average of $29.21. The company has a market capitalization of $198.99 million, a price-to-earnings ratio of 14.76 and a beta of 0.92. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $20.56 and a 12-month high of $34.92.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Triumph Capital Management purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,481 shares of the company’s stock, valued at approximately $35,000.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.